318 results
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GLP-1 Agonists ... Weekly Ozempic (Semaglutide ... However, GLP-1's ... being studied (semaglutide ... #GLP1 #Agonists
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... the pancreas (GLP ... injection • Semaglutide ... dulaglutide, and semaglutide ... EricsMedicalLectures/featured #GLP1
GLP-1 Medications: Ozempic vs. Trulicib (semaglutide vs. dulaglutide) 

From my experience, Ozempic and Trulicity are the
GLP-1 Medications ... Trulicib (semaglutide ... commonly used GLP1 ... trial of Ozempic (semaglutide ... Ozempic #Trulicib #semaglutide
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
Rybelsus (oral semaglutide ... ) - First Oral GLP ... (& only) oral GLP1 ... It is semaglutide ... the injectable GLP1
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
CARB ABSORPTION INHIBITOR ... alpha-glucosidase inhibitor ... INCRETIN AGENTS • GLP ... Adlyxin) • DPP-4 Inhibitors ... - Prevents GLP
Algorithm for prescribing SGLT2 inhibitors and GLP1 agonists

This algorithm prioritizes the prescription of SGLT2i and GLP-1
prescribing SGLT2 inhibitors ... and GLP1 agonists ... of SGLT2i and GLP ... #SGLT2 #GLP1 #prescribing
HIV HAART Medications - Classification by Names and Mechanism - Updated 01/2021
 - NRTIs
 - NNRTIs
NNRTIs - Protease Inhibitors ... - Integrase Inhibitors ... Antagonist - Fusion Inhibitor ... - Attachment Inhibitor
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... Mechanisms of Action: Inhibits ... normally inactivates GLP ... combination therapy with GLP-I ... featured #DPP4 #Inhibitors
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Sulfonylureas GLP ... events TZDs DPP-4 inhibitors ... SGLT2 inhibitors
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
Table Aspirin - Inhibits ... combination with P2Y12 inhibitor ... in a-fib P2Y12 Inhibitors ... ticagrelor) - Inhibits ... , abciximab) - Inhibits